Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
China Resources Shuanghe Pharmaceutical Co., Ltd.
Log in to Sina Finance App and search 【Information Disclosure】 to see more evaluation levels.
This proposal needs to be submitted for approval at the shareholders’ meeting.
11 votes in favor, 0 votes against, 0 abstentions.
11 votes in favor, 0 votes against, 0 abstentions.
For the 2025 Independent Director’s Work Report, see the Shanghai Stock Exchange website www.sse.com.cn.
This proposal needs to be submitted for approval at the shareholders’ meeting.
11 votes in favor, 0 votes against, 0 abstentions.
See the Shanghai Stock Exchange website www.sse.com.cn for the 2025 Audit and Risk Management Committee Performance Report.
11 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Audit and Risk Management Committee: Approved.
11 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Audit and Risk Management Committee: Approved.
See the “2025 Profit Distribution Plan Announcement” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
This proposal needs to be submitted for approval at the shareholders’ meeting.
11 votes in favor, 0 votes against, 0 abstentions.
See the 2025 Annual Report on the Shanghai Stock Exchange website www.sse.com.cn.
See the 2025 Annual Report Summary on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
11 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Audit and Risk Management Committee: Approved.
11 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Audit and Risk Management Committee: Approved.
11 votes in favor, 0 votes against, 0 abstentions.
11 votes in favor, 0 votes against, 0 abstentions.
See the 2025 Internal Control Evaluation Report on the Shanghai Stock Exchange website www.sse.com.cn.
11 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Audit and Risk Management Committee: Approved.
11 votes in favor, 0 votes against, 0 abstentions.
11 votes in favor, 0 votes against, 0 abstentions.
See the 2025 Sustainable Development Report on the Shanghai Stock Exchange website www.sse.com.cn.
See the 2025 Sustainable Development Report Summary on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
11 votes in favor, 0 votes against, 0 abstentions.
See the “2025 ‘Quality Improvement and Efficiency Enhancement for Return’ Action Plan Evaluation Report and 2026 ‘Quality Improvement and Efficiency Enhancement for Return’ Action Plan Announcement” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
11 votes in favor, 0 votes against, 0 abstentions.
See the “Announcement on the Achievement of the First Lock-up Period Release Conditions for the 2021 Restricted Stock Incentive Plan” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
Chairman Mr. Lu Wenchao, as the incentive object of the 2021 Restricted Stock Incentive Plan, will recuse himself from voting.
10 votes in favor, 0 votes against, 0 abstentions.
Opinion of the Compensation and Assessment Committee: Approved.
See the “Announcement on the Repurchase and Cancellation of Restricted Stocks Granted but Not Yet Unlocked” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
11 votes in favor, 0 votes against, 0 abstentions.
Due to the repurchase and cancellation of 10,059 restricted stocks granted to incentive objects that have not yet been unlocked, resulting in changes to the company’s total shares and registered capital, the company agrees to reduce registered capital to 1,038,572,452 yuan.
See the “Announcement on Changing Registered Capital and Amending the Articles of Association” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.”
This proposal needs to be approved at the shareholders’ meeting.
11 votes in favor, 0 votes against, 0 abstentions.
Due to changes in total shares and registered capital caused by the repurchase and cancellation of restricted stocks granted to incentive objects that have not yet been unlocked, the company agrees to amend the Articles of Association accordingly.
See the “Announcement on Changing Registered Capital and Amending the Articles of Association” on the Shanghai Stock Exchange website www.sse.com.cn and in the “China Securities Journal,” “Shanghai Securities News,” and “Securities Times.” The full text of the Articles of Association is available on the Shanghai Stock Exchange website www.sse.com.cn.
This proposal needs to be approved at the shareholders’ meeting.
11 votes in favor, 0 votes against, 0 abstentions.
Agree to hold the 2025 Shareholders’ Meeting, with the Chairman authorized to determine the specific date and location at an appropriate time.
11 votes in favor, 0 votes against, 0 abstentions.
This announcement is hereby made.
China Resources Shuanghe Pharmaceutical Co., Ltd.
Board of Directors
March 20, 2026